ResearchMoz

China Medical Information System Industry Report, 2012-2014

SinoMarketInsight (SMI)
Published Date » 2012-10-17
No. Of Pages » 96
   
 At present, the investment on medical information system in China generally accounts for about 2% of the total medical revenue. The investment scale of medical information system in China is expected to exceed RMB 40 billion in 2015, with CAGR achieving 26.3%. 
   
 The medical resources are insufficient and unevenly distributed in China. As large hospitals have more doctors and provide better medical services, people prefer large hospitals regardless of the severity of illness; as a result, the facilities such as bed are in serious shortage in large hospitals, while those in small hospitals and community healthcare stations are idle. However, the insufficiency, uneven distribution and low efficiency of medical resources have become a big problem in China, and the integration of...
Table of Content

1. Overview of Medical Information System
1.1 Definition of Medical Information System
1.2 Classification of Medical Information System

2. Development of Medical Information System in China
2.1 Current Situation of Medical Services
2.1.1 Medical and Health Resource Configuration is Unbalanced
2.1.2 Low Efficiency of Health Care Resources Wastes Resources
2.2 Policies of Medical Information System in China
2.3 Construction Progress of Medical Information System in China
2.3.1 Policies to Promote the Process of Chinese Medical Information System
2.3.2 Capital Input of Chinese Medical Information System
2.4 Competition of Chinese Medical Information System

3. Construction of International Medical Information System
3.1 Progress of Developed Countries Medical Information System
3.1.1 England
3.1.2 USA
3.1.3 Japan
3.1.4 Korea
3.2 Overview of American Medical Information System
3.2.1 Present Situation
3.2.2 Market Distribution
3.3 Comparison of Chinese and American Medical Information System

4. Development Trend of Chinese Medical Information System
4.1 Chinese Medical Information System is Expected to Fast Grow
4.1.1 HIS, CIS will Expand the Market Capacity
4.1.2 MIS and CIS Integration is Low
4.2 Accelerated the Construction of Primary Health Institutions
4.3 Social Security Card Promote Information System Comprehensive Upgrade
4.4 Leading Enterprises will Increase Market Share

5. Analysis of Key Enterprises
5.1 Winning Software
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Clients and Suppliers
5.1.5 Prospects and Performance Prediction in 2012-2014
5.1.6 Shareholding Companies
5.2 Neusoft Medical
5.2.1 Profile
5.2.2 Operation
5.2.3 Development Prospects of Xikang Health Management Platform
5.2.4 Development Prospects of Medical System Business
5.3 DHC
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Clients
5.3.5 Prospects and Performance Prediction in 2012-2014
5.3.6 Development Prospects
5.4 Tianjian Technology
5.4.1 Profile
5.4.2 Development Prospects
5.5 Wonders Information
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Clients and Suppliers
5.5.5 Prospects and Performance Prediction in 2012-2014
5.5.6 Equity Investment Projects
5.6 UFIDA Healthcare
5.6.1 Profile
5.6.2 Development Prospects
5.7 Enjoyor Share
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Clients
5.7.5 Prospects and Performance Prediction in 2012-2014
5.8 Yilianzhong
5.8.1 Profile
5.8.2 Operation
5.8.3 Revenue Structure
5.8.4 Prospects and Performance Prediction in 2012-2014
5.8.5 Shareholding Companies
5.9 Zhonglian Soft
5.9.1 Profile
5.9.2 Development Prospects
5.10 Kingdee Medical
5.10.1 Profile
5.10.2 Development Prospects

List of Tables


Classification of Medical Information System
Classification, Function and Subsystem of Medical Information in Narrow Sense
Total Number of Healthcare Institutions in China, 2006-2010
Number of Hospitals in China by Type, 2011
Number of Healthcare Institutions and Beds in China, 2009-2010
Number of Beds in Healthcare Institutions by Region in China (per Thousand Population), 2009
Medical Service Workloads and Bed Occupancy Rate of Hospital in China (by Level)
Medical Expenses and % of GDP in China, 2008-2011
Treatment Flow of One Hospital in China
Medical Information System Solutions for Easing Difficulty in Seeing a Doctor
Policies on Medical Information in China, 2011
Policies on Medical Information in China, 2002-2010
Comparison of Clinical Information Subsystems by Coverage, 2007 and 2010
Chinese Tertiary Hospitals Attention to Medical Information System Products
China's Financial Budget and Final Accounts, 2011
Hospital Information System Investment in China by Region
Funds of Different Levels of Hospitals Investing in Information System in China, 2009
Revenue Scale of Leading Medical Information Providers in China, 2011
Medical Expenses in the USA, 1970-2010
IT Budget of Hospitals in the USA, 2010
Industry Chain Distribution of Medical IT Suppliers in the USA
IT Solutions Market Size in China Medical Treatment Industry, 2009-2014E
China's Investments in Medical Information System, 2010-2015
Implementation of Clinical Information System in Chinese Hospitals, 2010
Construction of Rural Three-level Medical System in China, 2009-2010
Construction of Sanitation Service System in Communities around China, 2009-2010
Average Health Expenditure Constitutes in China, 2010
Employees and R&D Investment of Winning, 2008-2011
Categories and Functions of Winning Software Product
Financial Data of Winning, 2008-2012
Revenue Structure of Winning by Product, 2008-2012
Gross Margin of Winning by Product, 2008-2012
Revenue Structure of Winning by Region, 2008-2012
Revenue Contribution of Winnings Top 5 Clients, H1 2012
Revenue Contribution of Winnings Top 5 Clients, 2011
Procurement Amount of Winnings Top 5 Suppliers, 2011
Performance Prediction of Winning, 2012-2014
Net Income of Winnings Shareholding Companies, 2010-2011
Revenue and Net Income of Neusoft Medical, 2007-2011
Financial Data of Neusoft Medical, 2008-2012
Employees and R&D Investment of DHC, 2007-2011
Financial Data of DHC, 2007-2012
Revenue Structure of DHC by Product, 2007-2012
Profit & Gross Margin of DHC by Product, 2008-2012
Revenue Structure of DHC by Industry, 2007-2012
Revenue Contribution of DHCs Top 5 Clients, H1 2012
Revenue Contribution of DHCs Top 5 Clients, 2011
Performance Prediction of DHC, 2012-2014
Employees and R&D Investment of Wonders Information, 2008-2011
Financial Data of Wonders Information, 2007-2012
Major Business of Wonders Information
Revenue Structure of Wonders Information by Product, 2007-2012
Profit & Gross Margin of Wonders Information by Product, 2008-2012
Revenue Structure of Wonders Information by Region, 2009-2012
Revenue Contribution of Wonders Informations Top 5 Clients, 2011
Procurement Amount of Wonders Informations Top 5 Suppliers, 2011
Performance Prediction of Wonders Information, 2012-2014
Equity Investment Projects and Investment of Wonders Information
Revenue and Net Income of UFIDA Healthcare, 2009-2011
G Series Product System of UF Medical
Employees and R&D Investment of Enjoyor, 2007-2011
Financial Data of Enjoyor, 2007-2012
Revenue Structure of Enjoyor by Product, 2008-2012
Profit & Gross Margin of Enjoyor by Product, 2008-2012
Revenue Structure of Enjoyor by Region, 2007-2012
Name List and Revenue Contribution of Enjoyors Top 5 Clients, H1 2012
Name List and Revenue Contribution of Enjoyors Top 5 Clients, 2011
Performance Prediction of Enjoyor, 2012-2014
Employees and R&D Investment of Yilianzhong 2009-2011
Financial Data of Yilianzhong, 2007-2012
Revenue Structure of Yilianzhong by Product, 2007-2012
Revenue Structure of Yilianzhong by Region, 2007-2012
Performance Prediction of Yilianzhong, 2012-2014
Yilianzhong Issued 700 Million New Cards to Estimate the Corresponding Market
Net Income of Yilianzhongs Shareholding Companies, 2010-2011
Products and Solutions of Zhonglian Soft

List of Figures

NA

Upcoming Reports:

Smart Windows Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018
By - Transparency Market Research
The smart windows market is emerging as a good revenue generator for the actively involved companies. There are a variety of factors responsible for driving this sudden growth. Some of the factors are as follows: Growing consumer attention towards energy conservation, green buildings, and fuel efficient transportation  Larger addressable markets as a result of emerging middle class populations in developing countries  Emergences of new smart window technologies are providing growth opportunities for various companies involved in the smart...
Greece: cereals market
By - Williams and Marshal Strategy
This report presents a comprehensive overview of the cereals market in Greece and its state as of January 2014. It provides detailed analysis of the industry, its dynamics and structure. The purpose of the report is to describe the state of the cereals market in Greece, to present actual and retrospective information about the volumes and dynamics of production, imports, exports and consumption, the characteristics of the market for the period 2008-2012 and to build a forecast for the market development until 2018. In the same way, the report presents an elaborate overview of the main...
Artificial Implants Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018
By - Transparency Market Research
Artificial implant is the procedure of replacement of a biological structure through a medical device. This medical device can be heart, dental fixtures or similar body parts enhancing or strengthening the damaged or existing biological structure. Medical implants are artificially manufactured or so called as manmade, contrast to the transplanting organs or tissue. Some of the implants include electronic devices too such as pacemaker while others are bioactive. The advent of the artificial implants has opened new horizons for the medical sector helping the patients with damaged...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...